Jianmin Pharmaceutical Group Co Ltd
Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells medicines in China. It provides medicines and pediatric drugs under the Jianmin, Longmu, and Yekaitai brand name. The company provides OTC, medical, and general health products, as well as consultation service. Jianmin Pharmaceutical Group Co.,Ltd. was founded in 1993 and is headquartered in Wuhan, China.
Jianmin Pharmaceutical Group Co Ltd (600976) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.034x
Based on the latest financial reports, Jianmin Pharmaceutical Group Co Ltd (600976) has a cash flow conversion efficiency ratio of 0.034x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥88.06 Million) by net assets (CN¥2.60 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Jianmin Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Jianmin Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Jianmin Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jianmin Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sanxiang Co Ltd
SHE:000863
|
0.010x |
|
Jupiter Wagons Limited
NSE:JWL
|
0.005x |
|
Central Plaza Hotel Public Company Limited
BK:CENTEL
|
0.071x |
|
Zhejiang Yongjin Metal Technology Co Ltd
SHG:603995
|
0.060x |
|
Klöckner & Co SE
PINK:KLKNF
|
-0.077x |
|
Jilin Yatai Group Co Ltd
SHG:600881
|
0.038x |
|
INVESTIS HOLDING SF-,10
F:IYP
|
N/A |
|
Regulus Therapeutics Inc
NASDAQ:RGLS
|
-0.154x |
Annual Cash Flow Conversion Efficiency for Jianmin Pharmaceutical Group Co Ltd (2003–2024)
The table below shows the annual cash flow conversion efficiency of Jianmin Pharmaceutical Group Co Ltd from 2003 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.45 Billion | CN¥234.27 Million | 0.096x | -19.62% |
| 2023-12-31 | CN¥2.26 Billion | CN¥268.39 Million | 0.119x | +2.92% |
| 2022-12-31 | CN¥1.87 Billion | CN¥215.87 Million | 0.116x | -30.07% |
| 2021-12-31 | CN¥1.57 Billion | CN¥259.18 Million | 0.165x | +74.20% |
| 2020-12-31 | CN¥1.32 Billion | CN¥125.54 Million | 0.095x | +53.92% |
| 2019-12-31 | CN¥1.21 Billion | CN¥74.45 Million | 0.062x | +10.97% |
| 2018-12-31 | CN¥1.15 Billion | CN¥63.60 Million | 0.056x | +74.75% |
| 2017-12-31 | CN¥1.11 Billion | CN¥35.20 Million | 0.032x | -71.21% |
| 2016-12-31 | CN¥1.03 Billion | CN¥113.84 Million | 0.110x | +127.22% |
| 2015-12-31 | CN¥997.36 Million | CN¥48.45 Million | 0.049x | -52.85% |
| 2014-12-31 | CN¥1.00 Billion | CN¥103.23 Million | 0.103x | +113.60% |
| 2013-12-31 | CN¥940.46 Million | CN¥45.36 Million | 0.048x | -55.63% |
| 2012-12-31 | CN¥903.10 Million | CN¥98.17 Million | 0.109x | +226.20% |
| 2011-12-31 | CN¥876.97 Million | CN¥-75.54 Million | -0.086x | -148.72% |
| 2010-12-31 | CN¥848.81 Million | CN¥150.08 Million | 0.177x | +117.47% |
| 2009-12-31 | CN¥820.32 Million | CN¥66.69 Million | 0.081x | -43.79% |
| 2008-12-31 | CN¥761.24 Million | CN¥110.11 Million | 0.145x | +1660.69% |
| 2007-12-31 | CN¥742.63 Million | CN¥-6.88 Million | -0.009x | -112.65% |
| 2006-12-31 | CN¥766.61 Million | CN¥56.18 Million | 0.073x | +260.73% |
| 2005-12-31 | CN¥759.65 Million | CN¥-34.63 Million | -0.046x | -877.87% |
| 2004-12-31 | CN¥705.12 Million | CN¥4.13 Million | 0.006x | -59.37% |
| 2003-12-31 | CN¥290.32 Million | CN¥4.19 Million | 0.014x | -- |